Healthtech to set up Irish logistics hub for EU distribution

Tissue Regenix Group plc, the regenerative medical devices company, announces that it has received  approval from the Irish Health Products Regulatory Authority (‘HPRA’), allowing it to set up a logistics hub in Ireland for the distribution of its allograft products within the European Union. 

The HPRA regulates medicines and devices in Ireland for the benefit of people and animals, inspecting companies and  facilities which test, make or distribute health products to ensure that they comply with relevant standards and  legislation.

Daniel Lee

Garforth-based Tissue Regenix has also signed an exclusive distributor contract with Spineart España for the distribution  of its allograft products in Spain. Spineart is a privately held medical device company that operates in over 60 markets, focused on simplifying surgery by designing, developing and promoting safe and efficient solutions to spine surgeons,  operating room teams and patients. 

Daniel Lee, chief executive of Tissue Regenix, commented: “Receiving HPRA approval is a great step for Tissue Regenix, as it will provide a logistics hub for the distribution of our allograft products to the European market. Following  this, we are delighted to be partnering with Spineart to bring our allograft products to more customers in the EU. Spineart have a large global footprint that we hope in time can be leveraged to bring our products to more customers  internationally.”